This page contains information that makes no mention of lupron, yet the information explains how the problems of lupron have come about and continue unchecked.

Disclosure of Industry Payments to Physicians (NEMJ abstract)

FDA "too cozy", "total inability to carry out mission"

"PhRMA Announces Revised Voluntary Guidelines To Prohibit Gifts to Physicians"

Pharm. Industry has "taken over"

FDA strengthens policy on vetting of advisers

Pharm. Industry influence on academia

A radical restructuring of American civil justice system

Anti-Preemption Petition

Amici Curiae briefs by prominent healthcare experts and jurists

Vioxx seedling link

FDA Medwatch link

Medicine's Continuing Education & Conflicts